# Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder

> **NCT03729128** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tzu-Yun Wang** · enrollment: 85 (actual)

## Conditions studied

- Stimulants Use Disorder

## Interventions

- **DRUG:** dextromethorphan and memantine (DM+MM)
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03729128
- **Lead sponsor:** Tzu-Yun Wang
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-24
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2020-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03729128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03729128, "Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03729128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*